These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 20409071)

  • 1. Should pre-transfusion screening RBC panels contain Wr(a+) cells?
    Coluzzi S; De Nicolò MC; Quattrocchi L; Neri A; Ferruzzi I; Girelli G
    Transfus Med; 2010 Oct; 20(5):337-40. PubMed ID: 20409071
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An acute haemolytic transfusion reaction caused by anti-Wr.
    Cherian G; Search S; Thomas E; Poole J; Davies SV; Massey E
    Transfus Med; 2007 Aug; 17(4):312-4. PubMed ID: 17680958
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Irregular antibodies: an assessment of routine prenatal screening.
    Solola A; Sibai B; Mason JM
    Obstet Gynecol; 1983 Jan; 61(1):25-30. PubMed ID: 6401853
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Solid phase technique versus gel centrifugation for detection of erythrocyte antibodies--a prospective study comparison the 2 antibody detection tests].
    Zeiler T; Thiele S; Kretschmer V
    Beitr Infusionsther Transfusionsmed; 1996; 33():17-21. PubMed ID: 8974691
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Anti-Ge2 in a Ge: -2, -3 patient].
    Durán-Suárez JR; Sánchez C; Herrero E; Hernández Sánchez JM
    Sangre (Barc); 1991 Aug; 36(4):319-21. PubMed ID: 1776112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A delayed hemolytic transfusion reaction (DHTR) with multiple alloantibodies (Anti-E, Jka, Dia, Fyb, and S) induced by E-antigen-negative, crossmatch-compatible blood.
    Yamane K; Yagihashi A; Sasaki M; Kuwashima K; Morio A; Watanabe N
    Immunopharmacol Immunotoxicol; 1998 Nov; 20(4):531-9. PubMed ID: 9805232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Allogeneic peripheral blood hematopoietic stem cell transplantation: guidelines for red blood cell immuno-hematological assessment and transfusion practice.Société Française de Greffe de Moelle.
    Lapierre V; Kuentz M; Tiberghien P
    Bone Marrow Transplant; 2000 Mar; 25(5):507-12. PubMed ID: 10713627
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overt immediate hemolytic transfusion reaction attributable to anti-Wr(a).
    Boctor FN
    Immunohematology; 2008; 24(3):113-5. PubMed ID: 19845079
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical case of the month. Mild hemolytic disease of the newborn due to an anti-Wr(a) antibody].
    Keutgens A; Monfort M; Wagemans D; Van Cauwenberge JR; Gérard C
    Rev Med Liege; 2012; 67(7-8):403-6. PubMed ID: 22984759
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The prevalence of red-cell antigens and antibodies in Malawi.
    M'baya B; Mfune T; Mogombo E; Mphalalo A; Ndhlovu D; Knight RC
    Transfus Med; 2010 Jun; 20(3):196-9. PubMed ID: 20015059
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Medicolegal assessment of blood transfusion errors--an interdisciplinary challenge.
    Padosch SA; Schmidt PH; Pedal I; Franchy C; Hoch J; Madea B
    Forensic Sci Int; 2007 Oct; 172(1):40-8. PubMed ID: 17222999
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A delayed hemolytic transfusion reaction due to irregular antibodies with an anti-Kidd(a) specificity].
    Mörsdorf S; Fritsch E; Wagner B; Seyfert UT; Wenzel E
    Dtsch Med Wochenschr; 1997 Oct; 122(43):1313-6. PubMed ID: 9410695
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence of Wra antigen and anti-Wra in a Spanish population.
    Arriaga F; Llopis F; de la Rubia J; Carpio N; Moscardó J; Marty ML
    Transfusion; 2005 Aug; 45(8):1324-6. PubMed ID: 16078920
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recurrent acute hemolytic transfusion reactions by antibodies against Doa antigens, not detected by cross-matching.
    Baumgarten R; van Gelder W; van Wintershoven J; Maaskant-Van Wijk PA; Beckers EA
    Transfusion; 2006 Feb; 46(2):244-9. PubMed ID: 16441602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selection of GP. Mur antigen-negative RBC for blood recipients with anti-'Mi
    Yang CA; Lin JA; Chang CW; Wu KH; Yeh SP; Ho CM; Chang JG
    Transfus Med; 2016 Oct; 26(5):349-354. PubMed ID: 27634577
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Production of soluble recombinant proteins with Kell, Duffy and Lutheran blood group antigen activity, and their use in screening human sera for Kell, Duffy and Lutheran antibodies.
    Ridgwell K; Dixey J; Scott ML
    Transfus Med; 2007 Oct; 17(5):384-94. PubMed ID: 17725551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Survival Time of Cross-Match Incompatible Red Blood Cells in Adult Horses.
    Tomlinson JE; Taberner E; Boston RC; Owens SD; Nolen-Walston RD
    J Vet Intern Med; 2015; 29(6):1683-8. PubMed ID: 26478135
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proof of homologous blood transfusion through quantification of blood group antigens.
    Nelson M; Popp H; Sharpe K; Ashenden M
    Haematologica; 2003 Nov; 88(11):1284-95. PubMed ID: 14607758
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unsatisfactory detection of an in vivo haemolytic anti-vel by the gel test.
    Neppert J; Bartz L; Clasen C
    Vox Sang; 1998; 75(1):70-1. PubMed ID: 9745158
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute haemolytic reaction due to anti-Wb: a case report.
    Wright T; Brown P; Marais I; Hong FS
    Vox Sang; 2013 Nov; 105(4):355-7. PubMed ID: 23679095
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.